Drawing for SENSILE

USPTO serial 79371736

SENSILE

Reviewed by CopyMark Law Group

Reg. 7464631Status 700Registered
Filing date
Status date
Registration date
Aug 6, 2024
Examiner
SEVERSON, JUSTIN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SENSILE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew M. Smith

Andrew M. Smith Resonate IP, LLCP.O. Box 1650Bend, OR 97709United States

Goods and services

ClassDescriptionStatusFirst use
010medical apparatus and instruments, namely, electromagnetic drug delivery apparatus for medical use, infusion and injection devices for administering drugs, drug delivery ports and pumps for delivering drugs beneath the skin; apparatus for blood and blood plasma analysis, apparatus for blood extraction and blood analysis, namely, hematology analyzers, hematology rheometers, blood gas analyzers, biochemistry analyzers, hemagglutinators, and chemiluminescence immunoassay analyzers for medical diagnostic uses; diagnostics and analysis apparatus for medical purposes, in particular blood glucose meters, devices for measuring glycaemia, namely, glocometers, and glycerin concentration meters; medical apparatus for introducing pharmaceutical preparations into the body, in particular apparatus for introducing insulin and glucagon, namely, jet injectors for medical purposes, and portable pumps and patch pumps for medical use, in particular mobile and portable pumps and patch pumps for the transcutaneous and subcutaneous administering of drugs and active ingredients for diabetes management, for the treatment of degenerative disorders of the central nervous system, and for therapies that periodically require the delivery of a certain total quantity of a formulated drug; insulin and glucagon pumps; belts for medical purposes; injection devices for medical purposes, namely, infusion pumps, syringes for injections, medical fluid injectors for transcutaneous and subcutaneous delivery of medication including insulin and glucagon, and brush pens and dispensation devices in the form of injection instruments with needles for accurate, precise dosing and application of medical or cosmetic creams and preparations; insulin and glucagon injection instruments with needles; medical test kits for diabetes monitoring for home or clinical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 21, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 31, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 31, 2025FIMPFINAL DISPOSITION PROCESSED—
Nov 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 6, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 6, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 21, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 1, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 22, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 17, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 17, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Apr 17, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 17, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 17, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 14, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 23, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2024DOCKASSIGNED TO EXAMINER—
Jul 7, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 29, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 8, 2023SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance